Fundz

Immusoft Receives $4M In Funding From The California Institute For Regenerative Medicine (Cirm)

PRIVATENov 29, 2021

Amount Raised

$4 Million

Round Type

Seed

SeattleBiotechnologyHealth Care

Description

Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation, a cell therapy company dedicated to improving the lives of patients with rare diseases, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company a $4M grant to support the development of its ISP-002 (for delivery of iduronate sulfatase) program in mucopolysaccharidosis type II (MPS II), an inherited disease for which patients have limited options.

Quick answer

Immusoft raised $4 Million in a Seed round, dated November 29, 2021. Immusoft is based in Seattle, Washington, United States.

How much did Immusoft raise?
Immusoft raised $4 Million in a Seed round on November 29, 2021.
What does Immusoft do?
Immusoft is a cell therapy company focused on developing novel therapies for rare diseases using sustained delivery of therapeutic proteins from a patient’s own cells.
Where is Immusoft based and how big is it?
Immusoft is based in Seattle, Washington, United States.
Who are the decision-makers at Immusoft?
Fundz holds 1 contact at Immusoft. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Immusoft that raised within 45 days of this round, from Fundz verified event records.

  • ONL Therapeutics raised $47M (Series B) on January 13, 2022.
  • SomnoMed Technologies raised $200K (Pre-Seed) on January 13, 2022.
  • Valitor raised $8.4M on January 12, 2022.
  • Gameto raised $27M on January 11, 2022.
  • PostEra Inc. raised $24M (Funding Round) on January 11, 2022.
  • Gameto raised $23M (Funding Round) on January 10, 2022.

Who to call at Immusoft, and when

A new round usually means Immusoft is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Immusoft raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Immusoft, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Immusoft. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Immusoft

Location

Seattle, Washington, United States

About

Immusoft is a cell therapy company focused on developing novel therapies for rare diseases using sustained delivery of therapeutic proteins from a patient’s own cells. The company is developing a technology platform called Immune System Programming (ISP™), which modifies a patient’s B cells and instructs them to produce gene-encoded medicines. The B cells that are reprogrammed using ISP become miniature drug factories that are expected to survive in patients and provide therapeutic benefit for many years. The company is based in Seattle, WA.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Immusoft raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Immusoft's next move

See what Strategic adds

Immusoft raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.